APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Edoxaban Tosilate Tablets and Generic Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Edoxaban Tosilate Tablets and Generic Drugs Industry Growth and Trends Forecast to 2032

Report ID 173987390128 December 202578 pages

Choose your research edition.

Industry ResearchEdoxaban Tosilate Tablets and Generic Drugs Industry Research Report 2026107 pages · $2,950 USDIndustry Growth & TrendsGlobal Edoxaban Tosilate Tablets and Generic Drugs Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Edoxaban Tosilate Tablets and Generic Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032173 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Edoxaban Tosilate Tablets and Generic Drugs Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Edoxaban Tosilate Tablets and Generic Drugs Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Edoxaban Tosilate Tablets and Generic Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Edoxaban Tosilate Tablets and Generic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Edoxaban Tosilate Tablets and Generic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Edoxaban Tosilate Tablets and Generic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Edoxaban Tosilate Tablets and Generic Drugs include Daiichi Sankyo, Lunan Pharmaceutical Group, Menarini Group and Simcere Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Edoxaban Tosilate Tablets and Generic Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Edoxaban Tosilate Tablets and Generic Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Edoxaban Tosilate Tablets and Generic Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Edoxaban Tosilate Tablets and Generic Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Edoxaban Tosilate Tablets and Generic Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Edoxaban Tosilate Tablets and Generic Drugs Market by Company

Daiichi Sankyo

Lunan Pharmaceutical Group

Menarini Group

Simcere Pharmaceutical

Edoxaban Tosilate Tablets and Generic Drugs Segment by Type

30 mg

60 mg

Other

Edoxaban Tosilate Tablets and Generic Drugs Segment by Application

Hospital

Clinic

Other

Edoxaban Tosilate Tablets and Generic Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Edoxaban Tosilate Tablets and Generic Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Edoxaban Tosilate Tablets and Generic Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Edoxaban Tosilate Tablets and Generic Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Edoxaban Tosilate Tablets and Generic Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Edoxaban Tosilate Tablets and Generic Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 30 mg Table 2. Major Company of 60 mg Table 3. Major Company of Other Table 4. Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Type (2021-2026) & (K Units) Table 6. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share in Volume by Type (2021-2026) Table 7. Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Type (2021-2026) & (US$ Million) Table 8. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share in Value by Type (2021-2026) Table 9. Global Edoxaban Tosilate Tablets and Generic Drugs Price by Type (2021-2026) & (US$/Unit) Table 10. Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Type (2027-2032) & (K Units) Table 11. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share in Volume by Type (2027-2032) Table 12. Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Type (2027-2032) & (US$ Million) Table 13. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share in Value by Type (2027-2032) Table 14. Global Edoxaban Tosilate Tablets and Generic Drugs Price by Type (2027-2032) & (US$/Unit) Table 15. North America Edoxaban Tosilate Tablets and Generic Drugs Sales by Type (2021-2026) & (K Units) Table 16. North America Edoxaban Tosilate Tablets and Generic Drugs Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Edoxaban Tosilate Tablets and Generic Drugs Sales by Type (2021-2026) & (K Units) Table 18. Europe Edoxaban Tosilate Tablets and Generic Drugs Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Edoxaban Tosilate Tablets and Generic Drugs Sales by Type (2021-2026) & (K Units) Table 22. Latin America Edoxaban Tosilate Tablets and Generic Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Edoxaban Tosilate Tablets and Generic Drugs Industry Trends Table 26. Edoxaban Tosilate Tablets and Generic Drugs Industry Drivers Table 27. Edoxaban Tosilate Tablets and Generic Drugs Industry Opportunities and Challenges Table 28. Edoxaban Tosilate Tablets and Generic Drugs Industry Restraints Table 29. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Company (2021-2026) Table 31. Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Company (2021-2026) & (K Units) Table 32. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Share by Company (2021-2026) Table 33. Global Edoxaban Tosilate Tablets and Generic Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Edoxaban Tosilate Tablets and Generic Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Edoxaban Tosilate Tablets and Generic Drugs Major Company Production Sites and Headquarters Table 36. Global Edoxaban Tosilate Tablets and Generic Drugs Company, Product Type & Application Table 37. Global Edoxaban Tosilate Tablets and Generic Drugs Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Edoxaban Tosilate Tablets and Generic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Edoxaban Tosilate Tablets and Generic Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Region (2021-2026) & (K Units) Table 42. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share in Volume by Region (2021-2026) Table 43. Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Region (2021-2026) & (US$ Million) Table 44. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share in Value by Region (2021-2026) Table 45. Global Edoxaban Tosilate Tablets and Generic Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Region (2027-2032) & (K Units) Table 47. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share in Volume by Region (2027-2032) Table 48. Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Region (2027-2032) & (US$ Million) Table 49. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share in Value by Region (2027-2032) Table 50. Global Edoxaban Tosilate Tablets and Generic Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Application (2021-2026) & (K Units) Table 53. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share in Volume by Application (2021-2026) Table 54. Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Application (2021-2026) & (US$ Million) Table 55. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share in Value by Application (2021-2026) Table 56. Global Edoxaban Tosilate Tablets and Generic Drugs Price by Application (2021-2026) & (US$/Unit) Table 57. Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Application (2027-2032) & (K Units) Table 58. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share in Volume by Application (2027-2032) Table 59. Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Application (2027-2032) & (US$ Million) Table 60. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share in Value by Application (2027-2032) Table 61. Global Edoxaban Tosilate Tablets and Generic Drugs Price by Application (2027-2032) & (US$/Unit) Table 62. North America Edoxaban Tosilate Tablets and Generic Drugs Sales by Application (2021-2026) & (K Units) Table 63. North America Edoxaban Tosilate Tablets and Generic Drugs Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Edoxaban Tosilate Tablets and Generic Drugs Sales by Application (2021-2026) & (K Units) Table 65. Europe Edoxaban Tosilate Tablets and Generic Drugs Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Edoxaban Tosilate Tablets and Generic Drugs Sales by Application (2021-2026) & (K Units) Table 69. Latin America Edoxaban Tosilate Tablets and Generic Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. Daiichi Sankyo Company Information Table 73. Daiichi Sankyo Business Overview Table 74. Daiichi Sankyo Edoxaban Tosilate Tablets and Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Daiichi Sankyo Edoxaban Tosilate Tablets and Generic Drugs Product Portfolio Table 76. Daiichi Sankyo Recent Development Table 77. Lunan Pharmaceutical Group Company Information Table 78. Lunan Pharmaceutical Group Business Overview Table 79. Lunan Pharmaceutical Group Edoxaban Tosilate Tablets and Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Lunan Pharmaceutical Group Edoxaban Tosilate Tablets and Generic Drugs Product Portfolio Table 81. Lunan Pharmaceutical Group Recent Development Table 82. Menarini Group Company Information Table 83. Menarini Group Business Overview Table 84. Menarini Group Edoxaban Tosilate Tablets and Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Menarini Group Edoxaban Tosilate Tablets and Generic Drugs Product Portfolio Table 86. Menarini Group Recent Development Table 87. Simcere Pharmaceutical Company Information Table 88. Simcere Pharmaceutical Business Overview Table 89. Simcere Pharmaceutical Edoxaban Tosilate Tablets and Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Simcere Pharmaceutical Edoxaban Tosilate Tablets and Generic Drugs Product Portfolio Table 91. Simcere Pharmaceutical Recent Development Table 92. North America Edoxaban Tosilate Tablets and Generic Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 93. North America Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2021-2026) & (K Units) Table 94. North America Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Country (2021-2026) Table 95. North America Edoxaban Tosilate Tablets and Generic Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 96. North America Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share Forecast by Country (2027-2032) Table 97. North America Edoxaban Tosilate Tablets and Generic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 98. North America Edoxaban Tosilate Tablets and Generic Drugs Market Size by Country (2021-2026) & (US$ Million) Table 99. North America Edoxaban Tosilate Tablets and Generic Drugs Market Share by Country (2021-2026) Table 100. North America Edoxaban Tosilate Tablets and Generic Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 101. North America Edoxaban Tosilate Tablets and Generic Drugs Market Share Forecast by Country (2027-2032) Table 102. Europe Edoxaban Tosilate Tablets and Generic Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 103. Europe Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2021-2026) & (K Units) Table 104. Europe Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Country (2021-2026) Table 105. Europe Edoxaban Tosilate Tablets and Generic Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 106. Europe Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share Forecast by Country (2027-2032) Table 107. Europe Edoxaban Tosilate Tablets and Generic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 108. Europe Edoxaban Tosilate Tablets and Generic Drugs Market Size by Country (2021-2026) & (US$ Million) Table 109. Europe Edoxaban Tosilate Tablets and Generic Drugs Market Share by Country (2021-2026) Table 110. Europe Edoxaban Tosilate Tablets and Generic Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 111. Europe Edoxaban Tosilate Tablets and Generic Drugs Market Share Forecast by Country (2027-2032) Table 112. Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 113. Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2021-2026) & (K Units) Table 114. Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Country (2021-2026) Table 115. Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 116. Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share Forecast by Country (2027-2032) Table 117. Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Market Size by Country (2021-2026) & (US$ Million) Table 119. Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Market Share by Country (2021-2026) Table 120. Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Market Share Forecast by Country (2027-2032) Table 122. Latin America Edoxaban Tosilate Tablets and Generic Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 123. Latin America Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2021-2026) & (K Units) Table 124. Latin America Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Country (2021-2026) Table 125. Latin America Edoxaban Tosilate Tablets and Generic Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 126. Latin America Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share Forecast by Country (2027-2032) Table 127. Latin America Edoxaban Tosilate Tablets and Generic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Latin America Edoxaban Tosilate Tablets and Generic Drugs Market Size by Country (2021-2026) & (US$ Million) Table 129. Latin America Edoxaban Tosilate Tablets and Generic Drugs Market Share by Country (2021-2026) Table 130. Latin America Edoxaban Tosilate Tablets and Generic Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Latin America Edoxaban Tosilate Tablets and Generic Drugs Market Share Forecast by Country (2027-2032) Table 132. Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 133. Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2021-2026) & (K Units) Table 134. Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Country (2021-2026) Table 135. Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 136. Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share Forecast by Country (2027-2032) Table 137. Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Market Size by Country (2021-2026) & (US$ Million) Table 139. Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Market Share by Country (2021-2026) Table 140. Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Market Share Forecast by Country (2027-2032) Table 142. Key Raw Materials Table 143. Raw Materials Key Suppliers Table 144. Edoxaban Tosilate Tablets and Generic Drugs Distributors List Table 145. Edoxaban Tosilate Tablets and Generic Drugs Customers List Table 146. Research Programs/Design for This Report Table 147. Authors List of This Report Table 148. Secondary Sources Table 149. Primary Sources List of Figures Figure 1. Edoxaban Tosilate Tablets and Generic Drugs Image Figure 2. Global Edoxaban Tosilate Tablets and Generic Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Edoxaban Tosilate Tablets and Generic Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Edoxaban Tosilate Tablets and Generic Drugs Sales (2021-2032) & (K Units) Figure 5. 30 mg Image Figure 6. Global 30 mg Sales YoY Growth (2021-2032) & (K Units) Figure 7. 60 mg Image Figure 8. Global 60 mg Sales YoY Growth (2021-2032) & (K Units) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Edoxaban Tosilate Tablets and Generic Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Edoxaban Tosilate Tablets and Generic Drugs Market Share by Type 2025 VS 2032 Figure 13. North America Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share in Volume by Type in 2025 Figure 14. North America Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share in Value by Type in 2025 Figure 15. Europe Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Europe Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share in Value by Type in 2025 Figure 19. Latin America Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Edoxaban Tosilate Tablets and Generic Drugs Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 27. Clinic Image Figure 28. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Edoxaban Tosilate Tablets and Generic Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Edoxaban Tosilate Tablets and Generic Drugs Market Share by Application 2025 VS 2032 Figure 33. North America Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share in Volume by Application in 2025 Figure 34. North America Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share in Value by Application in 2025 Figure 35. Europe Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Europe Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share in Value by Application in 2025 Figure 39. Latin America Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share in Value by Application in 2025 Figure 43. North America Edoxaban Tosilate Tablets and Generic Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Edoxaban Tosilate Tablets and Generic Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Edoxaban Tosilate Tablets and Generic Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Edoxaban Tosilate Tablets and Generic Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Edoxaban Tosilate Tablets and Generic Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Edoxaban Tosilate Tablets and Generic Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Edoxaban Tosilate Tablets and Generic Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Edoxaban Tosilate Tablets and Generic Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Edoxaban Tosilate Tablets and Generic Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Edoxaban Tosilate Tablets and Generic Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Edoxaban Tosilate Tablets and Generic Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Edoxaban Tosilate Tablets and Generic Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Edoxaban Tosilate Tablets and Generic Drugs Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Edoxaban Tosilate Tablets and Generic Drugs Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 30 mg
  • 60 mg
  • Other
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Daiichi Sankyo
  • Lunan Pharmaceutical Group
  • Menarini Group
  • Simcere Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Edoxaban Tosilate Tablets and Generic Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Edoxaban Tosilate Tablets and Generic Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Edoxaban Tosilate Tablets and Generic Drugs Market by Type
  6. 1.3.1 30 mg
  7. 1.3.2 60 mg
  8. 1.3.3 Other
  9. 1.4 Global Edoxaban Tosilate Tablets and Generic Drugs Market Size by Type
  10. 1.4.1 Global Edoxaban Tosilate Tablets and Generic Drugs Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Edoxaban Tosilate Tablets and Generic Drugs Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Edoxaban Tosilate Tablets and Generic Drugs Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Edoxaban Tosilate Tablets and Generic Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Edoxaban Tosilate Tablets and Generic Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Edoxaban Tosilate Tablets and Generic Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Edoxaban Tosilate Tablets and Generic Drugs Industry Trends
  2. 2.2 Edoxaban Tosilate Tablets and Generic Drugs Industry Drivers
  3. 2.3 Edoxaban Tosilate Tablets and Generic Drugs Industry Opportunities and Challenges
  4. 2.4 Edoxaban Tosilate Tablets and Generic Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Edoxaban Tosilate Tablets and Generic Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Edoxaban Tosilate Tablets and Generic Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Edoxaban Tosilate Tablets and Generic Drugs Price (2021-2026)
  4. 3.4 Global Edoxaban Tosilate Tablets and Generic Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Edoxaban Tosilate Tablets and Generic Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Edoxaban Tosilate Tablets and Generic Drugs Company, Product Type & Application
  7. 3.7 Global Edoxaban Tosilate Tablets and Generic Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Edoxaban Tosilate Tablets and Generic Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Edoxaban Tosilate Tablets and Generic Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Edoxaban Tosilate Tablets and Generic Drugs Tier 1, Tier 2, and Tier 3
4 Edoxaban Tosilate Tablets and Generic Drugs Regional Status and Outlook
  1. 4.1 Global Edoxaban Tosilate Tablets and Generic Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Edoxaban Tosilate Tablets and Generic Drugs Historic Market Size by Region
  3. 4.2.1 Global Edoxaban Tosilate Tablets and Generic Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Edoxaban Tosilate Tablets and Generic Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Edoxaban Tosilate Tablets and Generic Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Edoxaban Tosilate Tablets and Generic Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Edoxaban Tosilate Tablets and Generic Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Edoxaban Tosilate Tablets and Generic Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Edoxaban Tosilate Tablets and Generic Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Edoxaban Tosilate Tablets and Generic Drugs by Application
  1. 5.1 Edoxaban Tosilate Tablets and Generic Drugs Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Edoxaban Tosilate Tablets and Generic Drugs Market Size by Application
  6. 5.2.1 Global Edoxaban Tosilate Tablets and Generic Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Edoxaban Tosilate Tablets and Generic Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Edoxaban Tosilate Tablets and Generic Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Edoxaban Tosilate Tablets and Generic Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Edoxaban Tosilate Tablets and Generic Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Edoxaban Tosilate Tablets and Generic Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Daiichi Sankyo
  2. 6.1.1 Daiichi Sankyo Company Information
  3. 6.1.2 Daiichi Sankyo Business Overview
  4. 6.1.3 Daiichi Sankyo Edoxaban Tosilate Tablets and Generic Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Daiichi Sankyo Edoxaban Tosilate Tablets and Generic Drugs Product Portfolio
  6. 6.1.5 Daiichi Sankyo Recent Developments
  7. 6.2 Lunan Pharmaceutical Group
  8. 6.2.1 Lunan Pharmaceutical Group Company Information
  9. 6.2.2 Lunan Pharmaceutical Group Business Overview
  10. 6.2.3 Lunan Pharmaceutical Group Edoxaban Tosilate Tablets and Generic Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Lunan Pharmaceutical Group Edoxaban Tosilate Tablets and Generic Drugs Product Portfolio
  12. 6.2.5 Lunan Pharmaceutical Group Recent Developments
  13. 6.3 Menarini Group
  14. 6.3.1 Menarini Group Company Information
  15. 6.3.2 Menarini Group Business Overview
  16. 6.3.3 Menarini Group Edoxaban Tosilate Tablets and Generic Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Menarini Group Edoxaban Tosilate Tablets and Generic Drugs Product Portfolio
  18. 6.3.5 Menarini Group Recent Developments
  19. 6.4 Simcere Pharmaceutical
  20. 6.4.1 Simcere Pharmaceutical Company Information
  21. 6.4.2 Simcere Pharmaceutical Business Overview
  22. 6.4.3 Simcere Pharmaceutical Edoxaban Tosilate Tablets and Generic Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Simcere Pharmaceutical Edoxaban Tosilate Tablets and Generic Drugs Product Portfolio
  24. 6.4.5 Simcere Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Edoxaban Tosilate Tablets and Generic Drugs Sales by Country
  2. 7.1.1 North America Edoxaban Tosilate Tablets and Generic Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Edoxaban Tosilate Tablets and Generic Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Edoxaban Tosilate Tablets and Generic Drugs Market Size by Country
  6. 7.2.1 North America Edoxaban Tosilate Tablets and Generic Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Edoxaban Tosilate Tablets and Generic Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Edoxaban Tosilate Tablets and Generic Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Edoxaban Tosilate Tablets and Generic Drugs Sales by Country
  2. 8.1.1 Europe Edoxaban Tosilate Tablets and Generic Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Edoxaban Tosilate Tablets and Generic Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Edoxaban Tosilate Tablets and Generic Drugs Market Size by Country
  6. 8.2.1 Europe Edoxaban Tosilate Tablets and Generic Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Edoxaban Tosilate Tablets and Generic Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Edoxaban Tosilate Tablets and Generic Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Edoxaban Tosilate Tablets and Generic Drugs Sales by Country
  2. 10.1.1 South America Edoxaban Tosilate Tablets and Generic Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Edoxaban Tosilate Tablets and Generic Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Edoxaban Tosilate Tablets and Generic Drugs Market Size by Country
  6. 10.2.1 South America Edoxaban Tosilate Tablets and Generic Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Edoxaban Tosilate Tablets and Generic Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Edoxaban Tosilate Tablets and Generic Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Edoxaban Tosilate Tablets and Generic Drugs Value Chain Analysis
  2. 12.1.1 Edoxaban Tosilate Tablets and Generic Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Edoxaban Tosilate Tablets and Generic Drugs Production Mode & Process
  7. 12.2 Edoxaban Tosilate Tablets and Generic Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Edoxaban Tosilate Tablets and Generic Drugs Distributors
  10. 12.2.3 Edoxaban Tosilate Tablets and Generic Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst